Severity grading: CTCAE and protocol-specific grading scales
Master the CTCAE severity grading framework and protocol-specific grading scales, applying term-specific criteria to common adverse events encountered in clinical trials.
"Mild" is not a grade
A participant in a Phase II oncology trial reports nausea at her Week 4 visit. The coordinator writes "mild nausea" in the source document and moves on. But what does "mild" mean here? The participant says the nausea is tolerable -- she can still eat, still go to work. That sounds mild. Yet when the coordinator asks more carefully, it emerges that the participant has been eating only half of her usual meals for the past five days. She has not vomited, but her oral intake is measurably reduced.